1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine
C135H105BrN46O14S7 — CID 158864248
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPAC1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine
SMILESCN(C)C(=O)c1ccc(-c2ccc3ncc(S(=O)(=O)n4ncc5ncc(-c6cnn(C)c6)cc54)n3c2)cc1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccc(N7CCOCC7)cc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccccc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccsc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cncnc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(Br)cn45)c3c2)cn1
InChIInChI=1S/C27H24N8O3S.C26H22N8O3S.C23H17N7O2S.C21H15N9O2S.C21H15N7O2S2.C17H12BrN7O2S/c1-32-17-22(14-30-32)21-12-25-24(28-13-21)15-31-35(25)39(36,37)27-16-29-26-7-4-20(18-34(26)27)19-2-5-23(6-3-19)33-8-10-38-11-9-33;1-31(2)26(35)18-6-4-17(5-7-18)19-8-9-24-28-14-25(33(24)16-19)38(36,37)34-23-10-20(11-27-22(23)13-30-34)21-12-29-32(3)15-21;1-28-14-19(11-26-28)18-9-21-20(24-10-18)12-27-30(21)33(31,32)23-13-25-22-8-7-17(15-29(22)23)16-5-3-2-4-6-16;1-28-11-17(8-26-28)15-4-19-18(24-7-15)9-27-30(19)33(31,32)21-10-25-20-3-2-14(12-29(20)21)16-5-22-13-23-6-16;1-26-11-17(8-24-26)16-6-19-18(22-7-16)9-25-28(19)32(29,30)21-10-23-20-3-2-14(12-27(20)21)15-4-5-31-13-15;1-23-9-12(6-21-23)11-4-15-14(19-5-11)7-22-25(15)28(26,27)17-8-20-16-3-2-13(18)10-24(16)17/h2-7,12-18H,8-11H2,1H3;4-16H,1-3H3;2-15H,1H3;2-13H,1H3;2-13H,1H3;2-10H,1H3
InChIKeyJBALRFHYZKAQSO-UHFFFAOYSA-N
MW2900.01 g/mol
LogP17.79
Rot. Bonds25
About 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine
1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine (PubChem CID 158864248) has the molecular formula C135H105BrN46O14S7 and a molecular weight of 2900.01 g/mol. Its IUPAC name is 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine.
Molecular Properties
| Compound Name | 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine |
|---|---|
| PubChem CID | 158864248 |
| Molecular Formula | C135H105BrN46O14S7 |
| Molecular Weight | 2900.01 g/mol |
| Exact Mass | 2896.61 |
| IUPAC Name | 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine |
| SMILES | CN(C)C(=O)c1ccc(-c2ccc3ncc(S(=O)(=O)n4ncc5ncc(-c6cnn(C)c6)cc54)n3c2)cc1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccc(N7CCOCC7)cc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccccc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccsc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cncnc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(Br)cn45)c3c2)cn1 |
| InChI | InChI=1S/C27H24N8O3S.C26H22N8O3S.C23H17N7O2S.C21H15N9O2S.C21H15N7O2S2.C17H12BrN7O2S/c1-32-17-22(14-30-32)21-12-25-24(28-13-21)15-31-35(25)39(36,37)27-16-29-26-7-4-20(18-34(26)27)19-2-5-23(6-3-19)33-8-10-38-11-9-33;1-31(2)26(35)18-6-4-17(5-7-18)19-8-9-24-28-14-25(33(24)16-19)38(36,37)34-23-10-20(11-27-22(23)13-30-34)21-12-29-32(3)15-21;1-28-14-19(11-26-28)18-9-21-20(24-10-18)12-27-30(21)33(31,32)23-13-25-22-8-7-17(15-29(22)23)16-5-3-2-4-6-16;1-28-11-17(8-26-28)15-4-19-18(24-7-15)9-27-30(19)33(31,32)21-10-25-20-3-2-14(12-29(20)21)16-5-22-13-23-6-16;1-26-11-17(8-24-26)16-6-19-18(22-7-16)9-25-28(19)32(29,30)21-10-23-20-3-2-14(12-27(20)21)15-4-5-31-13-15;1-23-9-12(6-21-23)11-4-15-14(19-5-11)7-22-25(15)28(26,27)17-8-20-16-3-2-13(18)10-24(16)17/h2-7,12-18H,8-11H2,1H3;4-16H,1-3H3;2-15H,1H3;2-13H,1H3;2-13H,1H3;2-10H,1H3 |
| InChIKey | JBALRFHYZKAQSO-UHFFFAOYSA-N |
| XLogP | 17.79 |
| TPSA | 658.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 60 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 203 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2900.01 |
| LogP ≤ 5 | 17.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 60 |
Frequently Asked Questions
What is the IUPAC name of 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine?
The IUPAC name of 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine (CID 158864248) is 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine.
What is the SMILES notation for 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine?
The canonical SMILES for 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine is CN(C)C(=O)c1ccc(-c2ccc3ncc(S(=O)(=O)n4ncc5ncc(-c6cnn(C)c6)cc54)n3c2)cc1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccc(N7CCOCC7)cc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccccc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6ccsc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cncnc6)cn45)c3c2)cn1.Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(Br)cn45)c3c2)cn1.
What is the InChIKey of 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine?
The InChIKey is JBALRFHYZKAQSO-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H24N8O3S.C26H22N8O3S.C23H17N7O2S.C21H15N9O2S.C21H15N7O2S2.C17H12BrN7O2S/c1-32-17-22(14-30-32)21-12-25-24(28-13-21)15-31-35(25)39(36,37)27-16-29-26-7-4-20(18-34(26)27)19-2-5-23(6-3-19)33-8-10-38-11-9-33;1-31(2)26(35)18-6-4-17(5-7-18)19-8-9-24-28-14-25(33(24)16-19)38(36,37)34-23-10-20(11-27-22(23)13-30-34)21-12-29-32(3)15-21;1-28-14-19(11-26-28)18-9-21-20(24-10-18)12-27-30(21)33(31,32)23-13-25-22-8-7-17(15-29(22)23)16-5-3-2-4-6-16;1-28-11-17(8-26-28)15-4-19-18(24-7-15)9-27-30(19)33(31,32)21-10-25-20-3-2-14(12-29(20)21)16-5-22-13-23-6-16;1-26-11-17(8-24-26)16-6-19-18(22-7-16)9-25-28(19)32(29,30)21-10-23-20-3-2-14(12-27(20)21)15-4-5-31-13-15;1-23-9-12(6-21-23)11-4-15-14(19-5-11)7-22-25(15)28(26,27)17-8-20-16-3-2-13(18)10-24(16)17/h2-7,12-18H,8-11H2,1H3;4-16H,1-3H3;2-15H,1H3;2-13H,1H3;2-13H,1H3;2-10H,1H3.
What are the key properties of 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine?
1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine has a molecular weight of 2900.01 g/mol, XLogP of 17.79, 25 rotatable bonds, 0 hydrogen bond donors, and 60 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(6-bromoimidazo[1,2-a]pyridin-3-yl)sulfonyl-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine;N,N-dimethyl-4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]benzamide;6-(1-methylpyrazol-4-yl)-1-(6-phenylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;4-[4-[3-[6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridin-1-yl]sulfonylimidazo[1,2-a]pyridin-6-yl]phenyl]morpholine;6-(1-methylpyrazol-4-yl)-1-(6-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1-(6-thiophen-3-ylimidazo[1,2-a]pyridin-3-yl)sulfonylpyrazolo[4,5-b]pyridine is sourced from PubChem (CID 158864248), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158864248 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.